Sanofi And GSK Face DOJ Probes Over Zantac Cancer Risk
Both Sanofi-Aventis US LLC and GlaxoSmithKline LLC are facing U.S. Department of Justice investigations over Zantac and allegations the heartburn drug causes cancer, the companies have said in a pair of...To view the full article, register now.
Already a subscriber? Click here to view full article